Financials
- Market Capitalization 456.43 M
- Employee 71
- Founded 2010
- CEO N/A
- Website www.rezolutebio.com
- Headquarter Nevada, United States
- FIGI BBG001XWWHL4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.67
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2963 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 7.78 USD | -2.02% | -22.04% | -2.75% | +92.10% | 472.99 M USD | ||
| 2975 | OVID Ovid Therapeutics Inc. - Common Stock | 2.49 USD | +1.22% | -8.12% | +6.41% | +492.86% | 464.73 M USD | ||
| 2998 | CABA Cabaletta Bio, Inc. - Common Stock | 2.77 USD | +3.75% | -11.50% | -0.72% | +63.91% | 451.66 M USD | ||
| 3001 | EVMN Evommune, Inc. Common Stock | 12.45 USD | +3.75% | -10.50% | -38.46% | -28.12% | 448.43 M USD |